SEC Filing Analysis: Medpace Holdings, Inc. (MEDP)

Executive Summary

• Trading Significance: Medium
• Key Takeaway: A company officer, Susan E. Burwig, has filed a notice of proposed sale for 20,000 shares of common stock valued at approximately $12.2 million. This is part of a consistent pattern of sales by the insider over the last three months.
• Market Impact: The individual transaction is small relative to the company's market cap, but the recurring nature of sales from a key officer could be interpreted as a bearish signal by the market.

Company Information

Field	Value
Company	Medpace Holdings, Inc.
Ticker Symbol	MEDP
CIK	0001668397
Industry	Commercial Physical & Biological Research

Insider Information

Field	Value
Name	BURWIG SUSAN E
CIK	0001677418
Title/Position	Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	144
Transaction Date	2025-11-24 (Approximate Sale Date)
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	20,000
Price Per Share	~$609.15 (based on aggregate market value)
Total Value	$12,183,034.73
Shares Owned After	Not specified
Ownership Type	Not specified

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$12,183,034.73
% of Market Cap	0.073%
Shares Transacted	20,000
% of Shares Outstanding	0.071%
Materiality Assessment	Low (based on percentages), Medium (based on absolute value and pattern)

Impact Evaluation

• Market Cap Context: For a large-cap company with a market capitalization of $16.62 billion, this $12.2 million sale is not financially material on its own.
• Ownership Concentration: Post-transaction ownership is not disclosed, so a full assessment of the insider's remaining stake is not possible from this filing.
• Transaction Significance: The significance is elevated from 'Low' to 'Medium' not by the size of this single transaction relative to the company's scale, but by the pattern it represents. This filing, combined with sales in the preceding three months totaling 30,000 shares for ~$16.9M, shows consistent and substantial liquidation by a corporate officer.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Form 144 is a notice of intent, and the market often anticipates such sales. The transaction's size is unlikely to cause significant price dislocation given the stock's liquidity and the company's large market cap.

Volume & Sentiment

• Expected Volume Impact: Minimal to low. The transaction size is a small fraction of typical daily trading volume for a stock of this size.
• Sentiment Indicator: Neutral to slightly Bearish. While a single sale is routine, a pattern of multi-million dollar sales by an officer can be perceived negatively by investors, suggesting the insider may not see significant near-term upside.

Investment Insights

Positive Market Indicators

• The shares being sold were acquired via a stock option exercise, indicating the options were in-the-money and the sale is a form of compensation realization.

Risk Factors

• The primary risk signal is the consistent, high-value selling by a key officer over a three-month period, totaling over $29 million including this proposed sale. This may indicate a belief that the stock is fully valued.

Key Takeaways

1. An officer intends to sell $12.2M in stock, a transaction that is small relative to the company's size but large in absolute terms.
2. This sale is part of a larger pattern of insider selling, with four separate sales transactions reported or proposed within a three-month window.
3. The shares for this sale originated from a stock option exercise, a common reason for insider sales.

Additional Context

Transaction Notes

• The filing discloses three prior sales in the past 3 months: 10,000 shares on 09/03/2025, 2,000 shares on 10/27/2025, and 18,000 shares on 11/11/2025.